Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Thiel, J.
Giant cell arteritis - New treatment targets at the horizon.
Semin Arthritis Rheum. 2025; 152686
Doi: 10.1016/j.semarthrit.2025.152686
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Thiel Jens
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Increasing insights into the pathogenesis of giant cell arteritis (GCA) identified a large number of new treatment targets. Very recently clonal hematopoesis, immune ageing processes associated with inflammation and dysregulated immune checkpoints have been linked to the pathogenesis of GCA. Based on pathopyhsiological insights new treatment options such as Janus kinase inhibitors or IL-17A blocking antibodies are currently tested in GCA.